2024
Association Between Chemotherapy-Induced Peripheral Neuropathy and Low Anterior Resection Syndrome
Linhares S, Schultz K, Coppersmith N, Esposito A, Leeds I, Pantel H, Reddy V, Mongiu A. Association Between Chemotherapy-Induced Peripheral Neuropathy and Low Anterior Resection Syndrome. Cancers 2024, 16: 3578. PMID: 39518019, PMCID: PMC11545659, DOI: 10.3390/cancers16213578.Peer-Reviewed Original ResearchLow anterior resection syndromeChemotherapy-induced peripheral neuropathyAnterior resection syndromeSystemic therapyRectal cancerPeripheral neuropathyAssociated with low anterior resection syndromeRetrospective review of patientsPlatinum-based chemotherapy agentsLow anterior resectionReview of patientsSphincter-preserving surgeryRectal cancer treatmentNeoadjuvant chemoradiationTumor distanceAnal vergeAnterior resectionRetrospective reviewChemotherapy-inducedChemotherapy agentsSide effectsCancer treatmentDebilitating conditionPatientsCIPN
2010
Clinical Differences Between Solifenacin and Tolterodine
Mongiu A, Lerner L. Clinical Differences Between Solifenacin and Tolterodine. Current Bladder Dysfunction Reports 2010, 6: 1-6. DOI: 10.1007/s11884-010-0075-2.Peer-Reviewed Original ResearchOveractive bladderClinical efficacyDry mouthSide effectsTreatment of OABBothersome urinary symptomsTolerable side effectsMainstay of treatmentGood clinical efficacyInvoluntary detrusor contractionsGood clinical resultsSimilar side effectsAntimuscarinic therapyUrinary symptomsDetrusor contractionHead trialsOAB treatmentClinical differencesClinical resultsPubMed reviewUS prevalenceBetter outcomesSolifenacinTolterodineStudy participants